# Discovery Questions: Pathogen Evolution & Transmission Tracking

## Strategic and Public Health Questions

### Public Health Objectives and Current Challenges
1. **Primary Surveillance Challenges**
   - What are your most significant challenges in detecting and responding to infectious disease outbreaks?
   - How long does it currently take from pathogen sample collection to actionable surveillance information?
   - Which infectious diseases pose the greatest threat to your population, and what surveillance gaps exist?
   - How do you currently track transmission chains and identify outbreak sources?

2. **Current Genomic Surveillance Capabilities**
   - What genomic sequencing capabilities do you currently have for pathogen surveillance?
   - How do you currently integrate genomic data with epidemiological surveillance information?
   - What is your current capacity for processing and analyzing pathogen genomic sequences?
   - How do you currently share genomic surveillance data with national and international partners?

3. **Outbreak Response and Preparedness**
   - What is your current process for outbreak investigation and response coordination?
   - How do you currently assess the effectiveness of public health interventions during outbreaks?
   - What early warning systems do you have in place for emerging infectious disease threats?
   - How do you coordinate with international partners during cross-border disease events?

### Stakeholder Requirements and Use Cases

4. **Key Stakeholders and Decision Makers**
   - Which public health agencies, laboratories, and healthcare systems would be primary users?
   - What are the different information needs of epidemiologists, laboratory scientists, and public health officials?
   - How do you currently communicate genomic surveillance findings to policymakers and the public?
   - What coordination is needed with veterinary and environmental health partners (One Health approach)?

5. **Priority Pathogens and Disease Areas**
   - Which pathogens are highest priority for enhanced genomic surveillance (respiratory viruses, foodborne pathogens, etc.)?
   - Do you need capabilities for both routine surveillance and emergency outbreak response?
   - What seasonal or endemic diseases require continuous monitoring versus event-based surveillance?
   - Are there specific emerging threats or biodefense concerns that need specialized surveillance?

## Technical Infrastructure Questions

### Laboratory and Sequencing Capabilities

6. **Current Laboratory Infrastructure**
   - What laboratories in your network currently perform pathogen genomic sequencing?
   - What sequencing platforms and technologies are currently available (Illumina, Oxford Nanopore, PacBio)?
   - What is your current sequencing throughput capacity and turnaround time?
   - How are laboratory quality control and assurance programs currently managed?

7. **Sample Collection and Processing**
   - What is your current sample collection network and specimen transport system?
   - How do you currently handle sample prioritization and triage for sequencing?
   - What laboratory information management systems (LIMS) are currently in use?
   - How do you currently maintain sample integrity and chain of custody?

8. **Bioinformatics and Data Analysis**
   - What bioinformatics expertise and computational infrastructure do you currently have?
   - How do you currently perform sequence assembly, variant calling, and phylogenetic analysis?
   - What software tools and pipelines are currently used for genomic data analysis?
   - How do you currently manage and store large genomic datasets?

### Data Integration and Interoperability

9. **Surveillance System Integration**
   - How would genomic surveillance integrate with existing communicable disease surveillance systems?
   - What electronic health record (EHR) systems need integration for clinical data linkage?
   - How do you currently integrate laboratory data with epidemiological case investigation?
   - What contact tracing systems and platforms are currently in use?

10. **Data Standards and Interoperability**
    - What data standards and formats are currently used for surveillance data exchange?
    - How do you currently ensure data quality and consistency across different data sources?
    - What are your requirements for real-time versus batch data processing and analysis?
    - How do you currently handle data linkage and patient privacy protection?

## Genomic Analysis and Intelligence Requirements

### Phylogenetic and Evolution Analysis

11. **Phylogenetic Analysis Needs**
    - What types of phylogenetic analysis are most important for your surveillance objectives?
    - How important is real-time phylogenetic tree construction versus periodic batch analysis?
    - What level of bootstrap support and statistical confidence is required for phylogenetic inferences?
    - How do you need to handle recombination detection and analysis for specific pathogens?

12. **Variant Detection and Classification**
    - What variant classification systems need to be supported (WHO variants, Pango lineages, etc.)?
    - How should emerging variants of concern be automatically flagged and prioritized?
    - What functional annotation and impact prediction capabilities are needed?
    - How should antigenic and drug resistance mutations be specifically tracked?

13. **Evolution Prediction and Modeling**
    - What value would you see in predicting pathogen evolutionary trajectories?
    - How important is forecasting of antigenic drift for vaccine strain selection?
    - What role should machine learning play in predicting mutation patterns and fitness effects?
    - How should climate and environmental factors be integrated into evolution models?

### Transmission Analysis and Contact Tracing

14. **Transmission Network Analysis**
    - How important is genomic-informed contact tracing and transmission chain reconstruction?
    - What integration is needed with digital contact tracing platforms and applications?
    - How should genomic similarity thresholds be set for inferring transmission links?
    - What statistical confidence levels are required for transmission network inferences?

15. **Geographic and Temporal Analysis**
    - What geographic resolution is needed for transmission analysis (neighborhood, city, region, country)?
    - How should population mobility and travel data be integrated with genomic analysis?
    - What temporal windows are most relevant for transmission analysis of different pathogens?
    - How important is real-time versus retrospective transmission analysis?

## International Collaboration and Data Sharing

### Global Surveillance Networks

16. **International Database Integration**
    - Which international genomic databases require integration (GISAID, GenBank, regional databases)?
    - What are your requirements for automated data submission and retrieval?
    - How do you want to handle data acknowledgment, attribution, and citation requirements?
    - What metadata standards need to be supported for international data sharing?

17. **Cross-Border Collaboration**
    - Which countries or regions are most important for surveillance data sharing and collaboration?
    - What legal and regulatory frameworks govern international genomic data sharing?
    - How should data sovereignty and national security concerns be addressed?
    - What emergency protocols are needed for rapid international data sharing during outbreaks?

18. **WHO and Regional Organization Integration**
    - How should the system integrate with WHO Global Influenza Surveillance and Response System (GISRS)?
    - What integration is needed with regional surveillance networks (EU ECDC, Africa CDC, etc.)?
    - How should the system support WHO emergency response and pandemic preparedness activities?
    - What reporting capabilities are needed for International Health Regulations (IHR) compliance?

### Data Privacy and Security

19. **Privacy and Confidentiality**
    - What privacy protection measures are required for genomic surveillance data?
    - How should patient privacy be protected while enabling public health surveillance?
    - What consent and authorization frameworks apply to genomic surveillance activities?
    - How should data de-identification and anonymization be implemented?

20. **Security and Access Control**
    - What security classifications apply to different types of genomic surveillance data?
    - How should access controls be implemented for different user roles and organizations?
    - What audit and monitoring capabilities are required for data access and usage?
    - How should high-consequence pathogen data be specially protected?

## Implementation and Operational Questions

### Deployment Strategy and Timeline

21. **Implementation Priorities**
    - Which pathogens or disease areas should be prioritized for initial implementation?
    - Do you prefer a phased approach starting with specific laboratories or geographic regions?
    - What would constitute a successful pilot or proof-of-concept implementation?
    - What are your timeline expectations for achieving operational genomic surveillance capabilities?

22. **Resource Requirements and Constraints**
    - What budget range and funding sources are available for genomic surveillance implementation?
    - What staffing and training requirements need to be addressed for successful implementation?
    - What infrastructure limitations or constraints need to be considered?
    - How should implementation be coordinated across multiple agencies and organizations?

### Training and Capacity Building

23. **Skills and Expertise Development**
    - What training is needed for laboratory staff in genomic sequencing and bioinformatics?
    - How should epidemiologists be trained to interpret and use genomic surveillance data?
    - What bioinformatics and data science expertise needs to be developed or recruited?
    - How should public health officials be educated about genomic surveillance capabilities?

24. **Quality Assurance and Validation**
    - What quality control and assurance programs need to be established for genomic surveillance?
    - How should proficiency testing and external quality assessment be implemented?
    - What validation studies are needed to demonstrate surveillance system performance?
    - How should genomic surveillance data quality be monitored and maintained over time?

## Regulatory and Compliance Questions

### Laboratory Standards and Accreditation

25. **Laboratory Certification Requirements**
    - What laboratory accreditation and certification requirements apply to genomic surveillance?
    - How should Clinical Laboratory Improvement Amendments (CLIA) requirements be addressed?
    - What international laboratory standards need to be met (ISO 15189, CAP, etc.)?
    - How should laboratory biosafety and biosecurity requirements be implemented?

26. **Research and Surveillance Ethics**
    - What ethical review and oversight processes apply to genomic surveillance activities?
    - How should dual-use research of concern be identified and managed?
    - What institutional review board (IRB) oversight is required for surveillance versus research activities?
    - How should community engagement and public communication be handled?

### Regulatory Compliance and Reporting

27. **Public Health Regulations**
    - What public health reporting requirements apply to genomic surveillance findings?
    - How should genomic surveillance support International Health Regulations (IHR) compliance?
    - What emergency use authorizations or regulatory pathways apply during public health emergencies?
    - How should genomic surveillance data be used to support regulatory decision-making?

28. **Data Governance and Stewardship**
    - What data governance frameworks need to be established for genomic surveillance data?
    - How should data retention, archival, and deletion policies be implemented?
    - What intellectual property considerations apply to genomic surveillance data and methods?
    - How should commercial partnerships and technology transfer be managed?

## Future Capabilities and Innovation

### Emerging Technologies and Methods

29. **Advanced Sequencing Technologies**
    - What interest do you have in portable and point-of-care sequencing technologies?
    - How important are long-read sequencing capabilities for pathogen surveillance?
    - What role should metagenomic sequencing play in pathogen discovery and surveillance?
    - How should environmental sequencing be integrated with clinical surveillance?

30. **Artificial Intelligence and Machine Learning**
    - What AI/ML capabilities would be most valuable for genomic surveillance applications?
    - How important is automated interpretation and reporting of genomic surveillance findings?
    - What role should predictive modeling play in surveillance and outbreak response?
    - How should AI/ML models be validated and maintained for surveillance applications?

### Strategic Vision and Innovation

31. **Future State Vision**
    - What is your vision for genomic surveillance capabilities in 5-10 years?
    - How should genomic surveillance evolve to address emerging threats and technologies?
    - What new partnerships and collaborations would enhance genomic surveillance capabilities?
    - How should genomic surveillance contribute to broader One Health and global health security goals?

32. **Innovation and Research Integration**
    - How should genomic surveillance capabilities support infectious disease research activities?
    - What opportunities exist for innovation in genomic surveillance methods and technologies?
    - How should academic and industry partnerships enhance surveillance capabilities?
    - What role should genomic surveillance play in countermeasure development (vaccines, therapeutics)?

These discovery questions will help assess the current state, requirements, and implementation strategy for Pathogen Evolution & Transmission Tracking, ensuring that the solution addresses specific public health surveillance needs while integrating effectively with existing systems and international collaborative networks.